September is Ovarian Cancer Awareness Month, and we are proud to fund the outstanding research of Dr. David Spriggs, who has worked with Memorial Sloan Kettering Cancer Center, one of the best hospitals in the world, for over twenty years.
“In addition to the daily care of women with gynecologic cancers, I run clinical trials that are testing new, targeted drugs, and oversee a small research laboratory looking for answers to such questions as why certain tumors resist drug treatment and how genes can affect the development of tumors,” says Dr. Spriggs.
The David Spriggs Lab has focused its research in the area of ovarian cancer and drug resistance. Ovarian cancer is unique in that newly diagnosed disease is almost uniformly sensitive to chemotherapy yet nearly all patients will eventually succumb to resistant disease. The focus has been primarily directed at transcriptional and post transcriptional regulation.
Watch Dr. Spriggs as he is featured on our latest video, A Glorious Chorus, and check out our Upcoming Events to support a cancer research fundraiser in your area to allow us to continue funding the excellent work of Dr. Spriggs and our other research doctors.